However, PEGylated SSNs with complexed anti-EGFR siRNA showed much slower tumour growth rate, exerting significantly high tumour inhibitory effects with the average tumour volume of ~726.46 mm3 (almost 60% reduction), compared to the control and empty NPs treatment groups. Here, EGFR is linked to neoplasm.